These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 31309636)

  • 1. Molecular diagnostics in oral cancer and oral potentially malignant disorders-A clinician's guide.
    Yap T; Celentano A; Seers C; McCullough MJ; Farah CS
    J Oral Pathol Med; 2020 Jan; 49(1):1-8. PubMed ID: 31309636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Cancer Stem Cell Markers in Potentially Malignant Disorders of Oral Mucosa: A Meta-analysis.
    Saluja TS; Ali M; Mishra P; Kumar V; Singh SK
    Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):144-153. PubMed ID: 30315141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of serum synuclein-γ and squamous cell carcinoma antigen as diagnostic biomarkers in patients with oral squamous cell carcinoma and oral potentially malignant disorders.
    Chen L; Luo T; Yang J; Wang K; Liu S; Wei Y; Liu H; Xu J; Zheng J; Zeng Y
    J Oral Pathol Med; 2021 Feb; 50(2):165-174. PubMed ID: 33064859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
    Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
    Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular Vesicles in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders: A Systematic Review.
    Yap T; Pruthi N; Seers C; Belobrov S; McCullough M; Celentano A
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32054041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentially malignant disorders of the oral cavity: current practice and future directions in the clinic and laboratory.
    Dionne KR; Warnakulasuriya S; Zain RB; Cheong SC
    Int J Cancer; 2015 Feb; 136(3):503-15. PubMed ID: 24482244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive screening of a microRNA-based dysregulation signature in oral cancer and oral potentially malignant disorders.
    Yap T; Seers C; Koo K; Cheng L; Vella LJ; Hill AF; Reynolds E; Nastri A; Cirillo N; McCullough M
    Oral Oncol; 2019 Sep; 96():113-120. PubMed ID: 31422202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of light based detection systems for early detection of oral cancer and oral potentially malignant disorders: Systematic review.
    Nagi R; Reddy-Kantharaj YB; Rakesh N; Janardhan-Reddy S; Sahu S
    Med Oral Patol Oral Cir Bucal; 2016 Jul; 21(4):e447-55. PubMed ID: 26946209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral Squamous Cell Carcinoma Associated with Precursor Lesions.
    McCord C; Kiss A; Magalhaes MA; Leong IT; Jorden T; Bradley G
    Cancer Prev Res (Phila); 2021 Sep; 14(9):873-884. PubMed ID: 34193432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosurveillance profile of oral squamous cell carcinoma and oral epithelial dysplasia through dendritic and T-cell analysis.
    Pellicioli ACA; Bingle L; Farthing P; Lopes MA; Martins MD; Vargas PA
    J Oral Pathol Med; 2017 Nov; 46(10):928-933. PubMed ID: 28585308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of CD44 and CD133 expression in oral potentially malignant disorder and oral squamous cell carcinoma].
    Jiajia Q; Yan S; Changqing Y; Wenjing J; Han Z; Yuanpan C; Qiuyan L
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2017 Jun; 35(3):311-316. PubMed ID: 28675018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Histological Prognostic Factors of Recurrence and Malignant Transformation in a Large Series of Oral Potentially Malignant Disorders.
    Lorini L; Tomasoni M; Gurizzan C; Magri C; Facchetti M; Battocchio S; Romani C; Ravanelli M; Oberti A; Bozzola A; Bardellini E; Paderno A; Mattavelli D; Lombardi D; Grammatica A; Deganello A; Facchetti F; Calza S; Majorana A; Piazza C; Bossi P
    Front Oncol; 2022; 12():886404. PubMed ID: 35530364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cyclin-dependent kinases in oral potentially malignant disorders and oral squamous cell carcinoma.
    Kujan O; Huang G; Ravindran A; Vijayan M; Farah CS
    J Oral Pathol Med; 2019 Aug; 48(7):560-565. PubMed ID: 31172620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of Candida species diversity among patients with oral squamous cell carcinoma and oral potentially malignant disorders.
    Sankari SL; Mahalakshmi K; Kumar VN
    BMC Res Notes; 2020 Oct; 13(1):488. PubMed ID: 33081839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution tumour models paving the way for understanding oral carcinogenesis.
    Martins-Chaves RR; Silva RSO; Pereira TDSF; Fonseca FP; Gomez RS
    J Oral Pathol Med; 2023 Apr; 52(4):294-299. PubMed ID: 36622735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. History and future perspectives for the use of fluorescence visualization to detect oral squamous cell carcinoma and oral potentially malignant disorders.
    Tomo S; Miyahara GI; Simonato LE
    Photodiagnosis Photodyn Ther; 2019 Dec; 28():308-317. PubMed ID: 31600576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could salivary biomarkers be useful in the early detection of oral cancer and oral potentially malignant disorders, and is there a relationship between these biomarkers and risk factors?
    Elmahgoub F
    Evid Based Dent; 2022 Mar; 23(1):30-31. PubMed ID: 35338326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological significance of 5-hydroxymethylcytosine in oral epithelial dysplasia and oral squamous cell carcinoma.
    Cuevas-Nunez MC; Gomes CBF; Woo SB; Ramsey MR; Chen XL; Xu S; Xu T; Zhan Q; Murphy GF; Lian CG
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Jan; 125(1):59-73.e2. PubMed ID: 28743666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point-of-care Analysis for Non-invasive Diagnosis of Oral cancer (PANDORA): A technology-development proof of concept diagnostic accuracy study of dielectrophoresis in patients with oral squamous cell carcinoma and dysplasia.
    Hughes MP; Labeed FH; Hoettges KF; Porter S; Mercadante V; Kalavrezos N; Liew C; McCaul JA; Kulkarni R; Cymerman J; Kerawala C; Barber J; Lewis MP; Fedele S
    J Oral Pathol Med; 2023 Apr; 52(4):305-314. PubMed ID: 36811206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmable bio-nanochip-based cytologic testing of oral potentially malignant disorders in Fanconi anemia.
    Floriano PN; Abram T; Taylor L; Le C; Talavera H; Nguyen M; Raja R; Gillenwater A; McDevitt J; Vigneswaran N
    Oral Dis; 2015 Jul; 21(5):593-601. PubMed ID: 25662766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.